.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Poster session

ePoster station 2

Termin

Datum: Do, 15.02.

Zeit: 16:00 – 17:00

Ort / Stream:

ePoster station 2

Chair

Programm

16:00 – 16:05 3 Min. 2 Min.
ePoster presentation
P12
DYRK1B on the cross-roads of tumor and stroma in pancreatic ductal adenocarcinoma
Dr. Anna Brichkina (Marburg / DE)
Pancreatic cancer
16:05 – 16:10 3 Min. 2 Min.
ePoster presentation
P13
ChatGPT vs. surgeons on pancreatic cancer queries: Accuracy & empathy evaluated by patients and experts
Dr. Rosa Klotz (Heidelberg / DE)
AI and decicion making in pancreatology
16:15 – 16:20 3 Min. 2 Min.
ePoster presentation
P15
Should octogenarians undergo resection in PDAC? A population-based analysis on effect of age on survival after resection of PDAC from the german clinical cancer registry group
Dr. med. Thaer S. A. Abdalla (Lübeck / DE)
Pancreatic cancer
16:20 – 16:25 3 Min. 2 Min.
ePoster presentation
P16
The oral microbiome is associated with preoperative imaging criteria and histological alterations in IPMN patients – a pilot study
Dr Christoph Ammer-Herrmenau (Goettingen / DE)
Cystic lesions of the pancreas
16:25 – 16:30 3 Min. 2 Min.
ePoster presentation
P17
Characterizing the impact of MAZ and cJUN in regulating inflammatory- and tumor- promoting gene programs in ARID1A-deficient PDAC subtypes
Maria Ulisse (Göttingen / DE)
Pancreatic cancer
16:35 – 16:40 3 Min. 2 Min.
ePoster presentation
P19
Revealing tertiary lymphoid structures as prognostic assets for amplifying antitumor immunity in pancreatic cancer
Dr. Carmen Mota-Reyes (München / DE)
Pancreatic cancer
16:40 – 16:45 3 Min. 2 Min.
ePoster presentation
P20
Mechanisms of resistance to targeted SHP2-inhibition +/- MAPK- or KRAS^G12D-inhibition in pancreatic cancer
Mr. Xun Chen (Freiburg im Breisgau / DE)
Pancreatic cancer
16:45 – 16:50 3 Min. 2 Min.
ePoster presentation
P21
A comprehensive multiomics approach unravels druggable tumor – stroma interactions in ATM-deficient pancreatic cancer
Elodie Roger (Ulm / DE)
Late breaking abstract
16:50 – 16:55 3 Min. 2 Min.
ePoster presentation
P22
DKK3 in pancreatic cancer – elucidating the roles of a double-edged sword
Dharini Srinivasan (Ulm / DE)
Late breaking abstract